ESETT Eligibility Overview

Slides:



Advertisements
Similar presentations
First Line Therapy in Acute Seizure Management William C. Dalsey, MD, MBA, FACEP Department of Emergency Medicine Robert Wood Johnson University Hospital.
Advertisements

Managing Seizure Patients in the Emergency Department Managing Seizure Patients in the Emergency Department James Wheless, MD Director, Texas Comprehensive.
Seizures: Nuts and Bolts
Status Epilepticus-Definition
Adverse Events and Serious Adverse Events. A 52 yo was found seizing and was appropriately enrolled. Her convulsions stop prior to ED arrival. After recovering.
Seizures: Nuts and Bolts National Pediatric Nighttime Curriculum Written by Anna Lin, MD Lucile Packard Children’s Hospital.
Epilepsy 2 Dr. Hawar A. Mykhan.
Post-RAMPART Implementation of Midazolam in EMS (PRIME) A retrospective, observational study of the use of IM midazolam.
SeizureStat © A PDA Software for Seizure/SE Therapeutics and the 2004 ACEP Seizure Clinical Policy Edward P. Sloan, MD, MPH, FACEP Associate Professor.
 Brief (
Neurological Emergencies Dr. Amal Alkhotani MBBCH, FRCPC, Epilepsy and EEG.
Seizures: Nuts and Bolts Nightfloat Curriculum Lucile Packard Children’s Hospital Residency Program.
Neurological Emergencies Treatment Trials Network RAMPART Overview Robert Silbergleit.
Investigator Meeting January 2010 Protocol Review and Refresher.
The ESETT Study Principal Investigator Name. What is Status Epilepticus? Status Epilepticus is seizure activity that does not stop It can cause unconsciousness.
Procedural Sedation Pharmacology Deb Updegraff R.N., P.N.P, C.N.S. Clinical Nurse Specialist LPCH Pediatric Intensive Care Unit.
Status Epilepticus (SE): Rx Following Benzodiazepine Use Edward Sloan, MD, MPH Associate Professor Department of Emergency Medicine University of Illinois.
Acute Seizure Management Neurology Rotation Lecture Series Last Updated by Lindsay Pagano Summer 2013.
First Line Therapy in Acute Seizure Management William C. Dalsey, MD, FACEP, MBA Department of Emergency Medicine Robert Wood Johnson University Hospital.
Pediatric Prehospital Seizure Management: Evidence Based Guidelines and State of Care in CO Kathleen Adelgais, MD MPH Pediatric Emergency Medicine Children’s.
Principal Investigator
Benzodiazepines What are the Best Non-IV Parenteral Options for a Seizing Patient? William C. Dalsey, MD, FACEP, MBA Department of Emergency Medicine Robert.
Managing and Detecting Seizures in the ICU Special thanks to: Katherine Nickels, MD Assistant Professor of Neurology and Pediatrics Mayo Clinic.
ACEP Clinical Policy: ACEP Clinical Policy: Critical Issues for the Evaluation and Management of Adult Patients Presenting With Seizures William C. Dalsey,
Edward P. Sloan, MD, MPH, FACEP Optimizing Seizure and SE Patient Management: Seizure Therapies Workshop and Clinical Policy Review.
Status epilepticus. Status Epilepticus Traditionally, SE is defined as continuous or repetitive seizure activity persisting for at least 30 minutes without.
Seizures Victoria Elliot. Outline Brief recap Management update Advantages and disadvantages of common antiepileptics Status epilepticus DVLA guidelines.
Progesterone and Traumatic Brain Injury. from: Progesterone is a female hormone important for the regulation of.
Management. Goals of emergency management for status epilepticus Ensure adequate brain oxygenation and cardiorespiratory function Terminate clinical and.
STEP BY STEP MANAGEMENT OF Seizures / STATUS EPILEPTICUS Dr. D. Alvarez 2007.
The Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial Brief Protocol Training NIH-NINDS U01 NS NETT CCC U01 NS NETT SDMC U01 NS
Investigator Kickoff Meeting January Protocol Review, Part 1 Robert Silbergleit, MD.
Copyright restrictions may apply Intranasal Midazolam vs Rectal Diazepam for the Home Treatment of Acute Seizures in Pediatric Patients With Epilepsy Holsti.
Paediatric Emergencies
A Randomised, Controlled Trial of Acetaminophen, Ibuprofen, and Codeine for Acute Pain relief in Children with Musculoskeletal Trauma Clark et al, Paediatrics.
Status epilepticus the paeds emerg perspective Stephen C. Porter MD MPH MSc Division Chief, Pediatric Emergency Medicine The Hospital for Sick Children.
First Line Therapy in Acute Seizure Management: Focusing on the Pediatric Patient William C. Dalsey, MD, FACEP, MBA Department of Emergency Medicine Robert.
Clinical Practice Guidelines 3 rd edition Prepared by [Insert name of presenter] [Insert title] [Insert Branch name] Day Month Year Infant & Children Acute.
Pre-hospital Management P.J. Wynnyk, M.D. Biochemistry of Seizures.
Status epilepticus PICU DIVISION.
Seizures LMH ER Rounds March 22, 2016 Prepared by Shane Barclay.
STATUS EPILEPTICUS STATUS EPILEPTICUS Time for a New Guideline for Management Prof Ashraf Abdou NEUROPSYCHIATRY DEPARTMENT FACULTY OF MEDICINE ALEXANDRIA.
Night Float Survival Guide Overnight Orientation
STATUS EPILEPTICUS (INVESTIGATION & MANAGEMENT)
Pediatric Pharmacology Overview
Investigator Kick-off Meeting Robert Silbergleit, MD
Objective 2 Discuss recent data, guidelines, and counseling points pertaining to the older adults with diabetes.
Diabetic hypoglycemia from prevention to management.
Therapeutics Tutoring
Established Status Epilepticus Treatment Trial (ESETT)
Foundations of Interprofessional Collaboration (FIPC): An Introduction to TeamSTEPPS® LEVEL 3 Overview of Clinical Management of Anaphylaxis for Respiratory.
Manage in Resuscitation Area
Anne Dobbs Lead ACP Emergency Medicine
Seizures in Childhood A seizure: is a transient occurrence of signs and/or symptoms resulting from abnormal excessive or synchronous neuronal activity.
Febrile Seizures Bradley K. Harrison, MD.
Background and Objectives
Status epilepticus Dr Karen Goodfellow.
Pharmacokinetics: Theophylline
Paediatric Daily Fluid Prescription & Balance Chart 2017
Medication In-Service:
A 2 y. o. male began seizing at home (generalized TC)
Buccal/ Nasal Midazolam
A 2 y. o. male began seizing at home (generalized TC)
Status Epilepticus: Clinical Features, Pathophysiology, and Treatment
Patient in Seizure: (PICU, medical/surgical floor) Total Seizure Time
Emergency Management of Seizures
Prepared by Shane Barclay MD
Evaluation and Management of Pediatric Seizures
“Anti Epileptic Drugs II”
MANDATORY INSULIN EDUCATION
Presentation transcript:

ESETT Eligibility Overview James Chamberlain, MD

Eligibility Age Convulsive Status Benzos Not excluded

Eligibility Age 2 years to < 18 years (Pediatric) 18 years to 65 years (Adult) > 65 years (Geriatric)

Eligibility Convulsive status Generalized tonic clonic May have started focally, then generalized May have been generalized but patient remains unconscious and exhibiting focal convulsions (i.e. motor activity) Unresponsive to pain (no pseudoseizures please) At least 5 minutes in total duration

Eligibility Benzos Adequate dose Within last 5-30 minutes Diazepam Lorazepam Midazolam Within last 5-30 minutes At least 5 minutes ago Not more than 30 minutes ago Prehospital meds count (including home meds) Adult (>32 kg) Child (< 32 kg) Diazepam 10 mg 0.3 mg/kg IV Lorazepam 4 mg 0.1 mg/kg Midazolam 0.3 mg/kg IM 0.2 mg/kg IV

Eligibility Summary The 5:30 rule At least 5 minutes of convulsive activity Last benzos at least 5 minutes ago Last benzos not more than 30 minutes ago

Eligibility Excluded Known pregnancy Prisoner Patient opted out of study Already treated with a second line agent Already sedated/paralyzed/intubated Acute traumatic brain injury Post cardiac arrest/anoxic seizures Known metabolic disorder Known liver disease Known severe renal disease Hypoglycemia (<50) or hyperglycemia (> 400) Known allergy to FOS, LEV, VPA Ethics/regulatory considerations Efficacy confounders These diseases are different Drug toxicity/metabolism Treatment is glucose management

Let’s Review: Vignette # 1 A 2 y. o Let’s Review: Vignette # 1 A 2 y.o. male began seizing at home (generalized TC). Parents gave Diastat 10 mg rectally and EMS gave 2 mg of midazolam (Versed) IM. He has not woken yet and on ED arrival he has rhythmic twitching of the left hand and forearm. With regard to his eligibility, He is not eligible because he is too young He is not eligible because he did not receive enough benzodiazepines He is not eligible because he is not in status He is eligible for enrollment and should be randomized He is not eligible because his seizures are focal only

Let’s Review: Vignette # 2 A 2 y. o Let’s Review: Vignette # 2 A 2 y.o. male began seizing at home earlier in the day. Parents gave Diastat 10 mg rectally and EMS gave 2 mg of midazolam (Versed) IM en route. He has been seizure-free in the ED for one hour. He starts to have generalized TC seizures. With regard to his eligibility, He is not eligible until he seizes for at least 5 minutes He is not eligible because he did not receive enough benzodiazepines He is not eligible because his benzodiazepines were too long ago A & C B & C

Let’s Review: Vignette # 3 A 2 y. o Let’s Review: Vignette # 3 A 2 y.o. male began seizing at home earlier in the day. Parents gave Diastat 10 mg rectally at 5 minutes. No additional meds given in ambulance. He arrives at the ED actively convulsing 40 minutes after seizure onset. He is eligible because continues to have seizures despite diazepam and should be randomized. He is not eligible because he only received rectal diazepam and needs to receive a dose of IV or IM benzodiazepenes before being eligible He is not eligible because his benzodiazepines were too long ago He is not eligible because he is too young B & C

Let’s Review: Vignette # 4 A 6 year old male with Lennox-Gastaut arrives in the ED with repeated brief convulsions with no recovery in between. Child is currently on Valproate, leviteracetam and clobazam. He is well known to ED staff with multiple visits, often in setting of intercurrent illness. Parents gave 10 mg rectal diazepam gel at home and he received 7.5 mg of midazolam IM in route. He is witnessed to still have brief 30-45 sec convulsions in ED without recovery in between. He is eligible because continues to have seizures despite diazepam and midazolam and should be randomized. He is not eligible because he is on valproate and leviteracetam He is not eligible because he is not in status He is not eligible because Lennox-Gastaut is not a localization related epilepsy B & C

Enrollment Overview

Enrollment Page the Study Team Use estimated weight if unknown (Broselow, etc) Open the “Use Next” Box for correct age group Start the Protocol Assist Device Use the Dosing Chart to draw up medication Second nurse confirm correct volume IV or IO route Use pump to deliver over 10 minutes Maintain usual care (monitoring, etc.)

Dosing chart will show this side Infusion Rate (mL/min) over 10 min   Subject Wt (kg) Infusion Vol. (mL) Infusion Rate (mL/min) over 10 min FOS dose (mg) LEV dose VPA dose 7.5 9 0.9 150 450 300 10 12 1.2 200 600 400 12.5 15 1.5 250 750 500 18 1.8 900 Etc. ≥75 90 1500 4500 3000

Enrollment and Dosing Open study box remove study drug Wt. (kg) Vol. 7.5 9 10 12 12.5 15 15 18 20 24 25 30 30 36 35 42 40 48 50 60 60 72 70 84 75 90 >75 90 Connect to patient IV catheter Estimate weight: Use Broselow like tape if necessary Dial appropriate volume in the infusion pump. Press start

Enrollment T0 = start of study drug infusion T10: medication should be finished T20: assess patient for ongoing status Clinical status persists  treatment failure  treat with another agent, intubate, etc. Clinical status stopped  assess responsiveness and wait for patient to recover T60: primary outcome determination

Continuous EEG If this is part of your hospital’s usual care Secondary study

Vignettes for enrollment? IV falls out/infiltrates at T5 minutes Assist device fails Patient still in status at 20 minutes and study team has not arrived yet Cannot reach study team at all Patient becomes apneic at 10 minutes

Questions